Literature DB >> 34938101

Study of the Diffusion Tensor Imaging for Preclinical Therapeutic Efficacy of Umbilical Cord Mesenchymal Stem Cell Transplantation in the Treatment of Spinal Cord Injury.

Ying Zhao1, Liqing Yao1, Lijuan Ao2, Jibing Ou1, Ying He1, Yunyun Shang1.   

Abstract

OBJECTIVE: In this study, umbilical cord mesenchymal stem cell (UC-MSC) transplantation was used to treat patients with spinal cord injury (SCI). The microstructural changes of the spinal cord before and after transplantation were observed by diffusion tensor imaging (DTI).
METHODS: From January 2014 to May 2015, seven patients who met the inclusion criteria were enrolled in this study. In the experimental group, both UC-MSC transplantation and comprehensive rehabilitation treatment were applied, while the control group received only comprehensive rehabilitation treatment. American Spinal Injury Association (ASIA) sensory and motor scores and the degree of SCI, spasticity, and urine/defecation functions were measured and evaluated together with DTI before the treatment and again at two and six months after the first treatment.
RESULTS: From the DTI, the changes in the fractional anisotropy (FA) value and the apparent diffusion coefficient (ADC) value were as follows: in the experimental group, there were significant differences in the FA and ADC values before and after treatment (P < 0.05) with a decreased ADC value and an increased FA value. The differences in the ADC and FA values of the normal layer and the lesion layer before and after treatment were compared. The differences in ADC and FA at the lesion layer before and after transplantation were greater than those of the normal layer, and the differences were statistically significant (P < 0.05). In the experimental group, one patient with incomplete SCI and one patient with a short course of complete SCI improved in terms of light touch, acupuncture sensation, and motor score. One patient with incomplete SCI achieved improvement in spasticity and urine/defecation functions.
CONCLUSION: The combination of UC-MSC transplantation and comprehensive rehabilitation therapy could help to promote the structural repair of the spinal nerve in patients with SCI.
© 2021 Zhao et al.

Entities:  

Keywords:  ADC; DTI; FA; spinal cord injury; stem cell

Year:  2021        PMID: 34938101      PMCID: PMC8686231          DOI: 10.2147/IJGM.S326023

Source DB:  PubMed          Journal:  Int J Gen Med        ISSN: 1178-7074


  18 in total

1.  Autologous Bone Marrow Stem Cells in Spinal Cord Injury; Our Experience in Clinical Studies, Animal Studies, Obstacles faced and steps for future.

Authors:  V Dedeepiya; S Manjunath; P Murugan; V Srinivasan; P Thamaraikannan; L Tholcopiyan; B Justin William; S Ayyappan; S Abraham
Journal:  J Stem Cells Regen Med       Date:  2010-10-30

Review 2.  A review of the emerging potential therapy for neurological disorders: human embryonic stem cell therapy.

Authors:  Geeta Shroff; Jyoti Dhanda Titus; Rhea Shroff
Journal:  Am J Stem Cells       Date:  2017-04-15

3.  MR diffusion tensor imaging and fiber tracking in spinal cord compression.

Authors:  David Facon; Augustin Ozanne; Pierre Fillard; Jean-François Lepeintre; Caroline Tournoux-Facon; Denis Ducreux
Journal:  AJNR Am J Neuroradiol       Date:  2005 Jun-Jul       Impact factor: 3.825

Review 4.  Mesenchymal stem cells in the treatment of spinal cord injuries: A review.

Authors:  Venkata Ramesh Dasari; Krishna Kumar Veeravalli; Dzung H Dinh
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

5.  Clinical Outcomes from a Multi-Center Study of Human Neural Stem Cell Transplantation in Chronic Cervical Spinal Cord Injury.

Authors:  Allan D Levi; Kim D Anderson; David O Okonkwo; Paul Park; Thomas N Bryce; Shekar N Kurpad; Bizhan Aarabi; Jane Hsieh; Katie Gant
Journal:  J Neurotrauma       Date:  2018-10-19       Impact factor: 5.269

6.  A new three dimensional biomimetic hydrogel to deliver factors secreted by human mesenchymal stem cells in spinal cord injury.

Authors:  Ilaria Caron; Filippo Rossi; Simonetta Papa; Rossella Aloe; Marika Sculco; Emanuele Mauri; Alessandro Sacchetti; Eugenio Erba; Nicolò Panini; Valentina Parazzi; Mario Barilani; Gianluigi Forloni; Giuseppe Perale; Lorenza Lazzari; Pietro Veglianese
Journal:  Biomaterials       Date:  2015-10-22       Impact factor: 12.479

7.  Development of the transcallosal motor fiber from the corticospinal tract in the human brain: diffusion tensor imaging study.

Authors:  Hyeok Gyu Kwon; Su Min Son; Sung Ho Jang
Journal:  Front Hum Neurosci       Date:  2014-03-18       Impact factor: 3.169

8.  The combined strategy of mesenchymal stem cells and tissue-engineered scaffolds for spinal cord injury regeneration.

Authors:  Rosaliana Libro; Placido Bramanti; Emanuela Mazzon
Journal:  Exp Ther Med       Date:  2017-08-16       Impact factor: 2.447

Review 9.  Mesenchymal Stem Cells for Spinal Cord Injury: Current Options, Limitations, and Future of Cell Therapy

Authors:  Fabio Cofano; Marina Boido; Matteo Monticelli; Francesco Zenga; Alessandro Ducati; Alessandro Vercelli; Diego Garbossa
Journal:  Int J Mol Sci       Date:  2019-05-31       Impact factor: 5.923

Review 10.  Stem Cells Therapy for Spinal Cord Injury: An Overview of Clinical Trials.

Authors:  Serena Silvestro; Placido Bramanti; Oriana Trubiani; Emanuela Mazzon
Journal:  Int J Mol Sci       Date:  2020-01-19       Impact factor: 5.923

View more
  1 in total

1.  Clinical translation of stem cell therapy for spinal cord injury still premature: results from a single-arm meta-analysis based on 62 clinical trials.

Authors:  Zhizhong Shang; Mingchuan Wang; Baolin Zhang; Xin Wang; Pingping Wanyan
Journal:  BMC Med       Date:  2022-09-05       Impact factor: 11.150

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.